Transaction · 0001193125-26-259705

POST LEONARD E

POST LEONARD E, DIR, reported a transaction classified as exercise at CG Oncology, Inc. involving 1000.000000 shares for an estimated $600.00. Reported holdings after the transaction were 1000.000000 shares. The stored filing text includes a detected 10b5-1 reference.

exerciseSEC transaction code MDIR
CGONCG Oncology, Inc.
Filing timeJun 05
Trade dateJun 04, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$53.72
Pre-filing
1mo ago +25.0%1w ago +13.0%1d ago +1.3%
Returns since
7d +10.9%30d +31.0%90d +46.6%180d +46.6%1y +46.6%

CGON price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
CGON since 2026-06-05Filed 91 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
exercise
Code M
Identifier
0001193125-26-259705
Common Stock
Transaction date
Jun 04, 2026
Filed Jun 05, 2026, 08:30 PM · 1d delay
Shares
1.00k sh
$60 per share
Estimated value
$60.0k
Computed from shares × price
Holdings after
1.00k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership Large Holdings Increase 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The option exercise and sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 5, 2026

  2. F2

    Fully vested.

  3. F3

    1/12th of the total number of shares of common stock subject to the option vest monthly following June 4, 2026, the date of grant (or, in the event the next annual meeting of the Issuer's stockholders…

Original filing · 0001193125-26-259705
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

CGON